Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgriterra Ld Regulatory News (AGTA)

Share Price Information for Agriterra Ld (AGTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.85
Bid: 0.70
Ask: 1.00
Change: 0.00 (0.00%)
Spread: 0.30 (42.857%)
Open: 0.85
High: 0.00
Low: 0.00
Prev. Close: 0.85
AGTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Dec 2023 10:30

RNS Number : 2174Y
Agriterra Ltd
29 December 2023
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Agriterra Limited / Ticker: AGTA / Index: AIM / Sector: Agriculture

 

Agriterra Limited ('Agriterra' or the 'Company')

 

Interim Results

 

Agriterra Limited, the AIM listed African agricultural company, announces its unaudited results for the six months ended 30 September 2023.

Chair's Statement

 

I am pleased to provide an update on our performance in the first half of the 2024 financial year ('HY-2024'). These results will be made available on the Company's website.

 

Operational update

 

Grain division

 

The Grain division commenced the period without sufficient reserves of maize in silo to link to the new season. Accordingly, with no banking facilities in place, early season maize purchases were funded by customer prepayments and advances, securing 4,500 tons in the first 3 months of the period. The Grain division´s objective was to breakeven during this low milling period whilst securing sufficient stocks for the season.

 

The division secured a commercial overdraft in July 2023 amounting to US$2 million to finance further maize purchases. However it was unable to draw on the full facility as the bank was unable to disburse the full amount due to Central Bank monetary policy to restrict the money supply. The division secured a shareholder loan in August for US$2 million to fund maize purchases.

 

In August 2023, the Grain division undertook a restructuring exercise with the objective of breaking even at 900 tons per month by:

 

· Revising the pricing strategy to achieve at least 25% gross margin on cost on maize.

· Reducing fixed overheads from MZN 6 million (approximately US$ 93,000) per month to MZN 3 million (approximately US$ 47,000) by:

Retrenching 54 staff members thereby reducing personnel cost MZN 2 million (approximately US$ 31,000) per month.

Reducing other operations cost by MZN 1 million (approximately US$ 16,000) per month.

 

The cash flow constraints in the early part of the period adversely impacted Grain division sales volumes at 4,188 tons (HY-2023: 7,947 tonnes) generating revenue of US$ 2.2 million (HY-2023: US$ 3.6 million).

 

The business, as at 30 September 2023, has in silo a total stock of 6,609 tons of maize (HY-2023: 7,444 tons), which will be rolled over continuously to fund maize requirements through to April 2024. This will necessitate the purchase of a further 5,000 tons to meet the milling requirements until the next harvest. Due to late purchasing and general shortage of maize, average cost of maize increased from MZN 12.2 per kg (approximately US$ 0.19) to MZN 19.1 per kg (approximately US$ 0.30) for the current season. However the shortage of maise has increased the price of meal and the division expects to be able to meet its margin targets in the second half of the year as demand improves.

 

Operating costs increased by US$ 0.1 million to US$ 0.6 million due to retrenchment cost incurred in August 2023. EBITDA decreased to a loss of US$ 0.2 million (HY-2023: EBITDA profit of US$ 0.2 million) due to lower volumes and margins in the first quarter. Finance costs decreased to US$ 0.2 million (HY-2023: US$ 0.8 million) reflecting the full benefits of the refinancing of commercial debt with shareholder loans in the prior year. Depreciation cost remained constant at US$ 0.24 million. Grain incurred a loss of US$ 0.68 million for the 6 months period ending 30 September 2023 (HY-2023: Loss US$ 0.87 million).

 

Beef division

 

The strategy in the beef division shifted midway through the period. This change was driven by several factors:

 

· Influx of cheap beef from South Africa due to the weakening of the South African Rand against the Metical which had an impact on the beef market in the Southern parts of Mozambique, especially Maputo, the Capital.

· Rising transport costs which has impacted on the landed cost of cattle in the feedlot as well as costs of getting the finished product to market. These rising costs can be attributed to: 

Deteriorating transport network

Rising fuel costs

Ageing fleet

 

In response, decisions were made to start shifting the sales strategy of beef from the more formal high-end market to less formal mass market, and price the product aggressively, whilst also maintaining our current strategy of conditioning animals in the feedlot and maintaining a presence within the formal market.

To achieve this, we have implemented the following:

 

· Start targeting areas much closer to our operational base for cattle buying.

· Buying animals at the feedlot and abattoir for slaughter directly.

· Start investing in new fleet of cattle trucks to improve transport efficiencies.

 

In addition to the above, a cost reduction exercise was undertaken at the end of July with a view of reducing our monthly operating expenses by 1,000,000 MZN per month (approximately US$ 16,000) as well as reducing our staff compliment by 45, in an effort to economise and streamline the operation. 

 

The number of animals in stock had reduced to 723 head by 30 Sept 23. This is partly as result of our shift in strategy to buy more animals for direct slaughter and reduce the amount and cost of keeping animals in the feedlot. Cashflow has had some challenges, primarily due to tough economic conditions as well as country wide municipal elections, with much funding from Government being diverted to campaigning rather than settling outstanding debts to their suppliers, which in turn impacts on primary producers like ourselves. Steps have been taken to rectify this and we are now seeing an improvement.

 

Beef division generated US$ 1.5 million revenue over the period, a reduction of US$ 145,000 against the same period last year. 430 tons of beef were sold during the period, compared to a budget of 652 tons. A gross profit of 20.67% was achieved, which is the third year whereby a GP of over 20% has been achieved.

 

Cash resources available at this time amounted to US$ 0.25 million which amounts to an additional 750 head of cattle at current prices. The cumulative for loss the period amounted to US$ 0. 4 million, an increase of US$ 0.1 million.

 

After some delays, we have started a new company Carnes de Manica and sales commenced in October 2023. This is another field to Pork initiative and once it is fully established, we anticipate an additional US$ 0.13 million to be added to the revenue stream annually. Current number of pigs in stock is 299 head.

 

Two new cattle trucks and trailers have been purchased at a cost of US$ 0.12 million with funds raised from Peterhouse Capital. We anticipate the arrival of these trucks in late Nov. This will help in improving our efficiencies and reducing our transport costs within the beef division.

 

Snax Division

 

Snax division continues to supply the market with superior quality products of which we have launched a new chicken flavoured puff ring over this period. The new product has been well received as now constitutes about 15% of total sales. Onion rings remain the market favourite and a new 100g family size packet is being launched. The new packing machine has been ordered and we expect this to be on site late December 2023 and installed, ready for production in January 2024. In terms of production we have produced 515 00 bales of product over the period.

Snax division generated revenue amounting to US$ 1.03 million (HY-2023: US$ 1.27 million) over the period with a gross profit of 20.17% (HY-2023: 19.6%). Decrease in sales revenue is mainly attributable to the tough economic conditions and less disposable household incomes, with families spending less on non-essential food stuffs. Profit for the period was US$ 0.30 million (HY-2023: US$ 0.74 million).

DECA Snax is a joint venture and based on International Financial Reporting Standards, revenue is not consolidated but the profit portion attributable to the group is included as share of profit in equity accounted investee in the Consolidated Income Statement. Profits have been negatively impacted by the rising costs of raw materials, packaging and transport. Maize prices in particular have had a significant impact. Profit attributable to the group is US$ 0.15 million (HY-23: US$ 0.35 million).

 

Group Results

Group revenue for the half-year ended 30 September 2023 decreased by 28% to US$ 3.6 million (HY-2023: US$ 5.0 million). Decrease in sales revenue is mainly resulting from decrease in sales for Grain division.

 

Gross profit decreased to US$ 0.5 million (HY-2023: US$ 1.1 million) achieving a group gross margin of 15% (HY-2023: Gross margin of 22%). Decrease in gross margin is resulting from high cost of maize which reduced Grain division margins to 9%. Group operating expenses increased from US$ 1,603 to US$ 1,727 due to retrenchment cost as compared to prior period. Following the restructuring exercise, it is anticipated that operating expenses will fall significantly from October 2023.

 

Finance costs decreased by 40% to US$ 0.55 million (HY-2023: US$ 0.92 million) as a result of refinancing of commercial debt with shareholder loans incurring interest at SOFR+3%. Overall interest rate on shareholder loan is around 10% per annum as compared to the current commercial debt interest rate of 25% per annum.

 

During the period, inventories have increased by US$ 1.92 million to US$ 2.47 million as compared to 31 March 2023. Grain division is keeping low inventory levels as a result of the revised strategy to reduce stock holding cost and finance cost in Grain division. Net debt at 30 September 2023 was US$ 12.7 million (31 March 2023: US$ 10.9 million).

 

Outlook for H2-2024

 

The Grain business is entering H2-2024 with 6,609 tons of grain in silo which is not sufficient to take us to the next harvest. The division is supplementing by importing 4000 tons of maize from South Africa and rolling to the extent possible maize sold during the period. Beef division sales revenue is expected to increase by 20% as compared to the first half year. All divisions have been striving to be self-sustaining at low capacity utilisation and now are expanding into profitable operations as volumes increase after rightsizing. Management will continuously monitor operations for profitability and seize new market opportunities creating a group basket of products to effectively lower overheads per product in the medium to long term.

 

Grain remains the core group business and management will seek to add value by creating additional product lines building on the success of Deca Snax.

 

 

CSO Havers

Chair

29 December 2023

 

 

 

 

For further information please VISIT www.agriterra-ltd.com or contact:

 

Agriterra Limited

Strand Hanson Limited

Caroline Havers

caroline@agriterra-ltd.com

Ritchie Balmer / James Spinney / David Asquith

Tel: +44 (0) 207 409 3494

Peterhouse Capital Limited

Duncan Vasey / Eran Zucker

Tel: +44 (0) 207 469 0930

 

 

Consolidated statement of profit or loss and other comprehensive income

Consolidated income statement

 

 

6 months

ended

30 September

2023

6 months

ended

30 September

2022

Year

ended

31 March

2023

 

 

Unaudited

Unaudited

Audited

 

 

 

 

Note

US$000

US$000

US$000

CONTINUING OPERATIONS

 

 

Revenue

2

3,575

4,964

11,494

Cost of sales

 

(3,054)

(3,883)

(8,758)

(Decrease)/Increase in fair value of biological assets

 

-

-

(288)

Gross profit

 

521

1,081

2,448

 

Operating expenses

 

(1,727)

(1,603)

(3,381)

 

 

Other income

 

143

56

122

Profit on disposal of property, plant and equipment

 

-

-

-

Operating loss

 

(1,063)

(466)

(811)

 

 

Net finance costs

3

(550)

(918)

(1,462)

Share of profit in equity-accounted investees, net of tax

 

15

35

37

Loss before taxation

 

(1,598)

(1,349)

(2,236)

 

 

Taxation

 

-

-

127

Loss for the period

2

(1,598)

(1,349)

(2,109)

 

 

 

 

 

Loss for the period attributable to owners of the Company

 

 

(1,598)

 

(1,349)

(2,109)

 

 

 

 

 

LOSS PER SHARE

 

 

 

 

Basic and diluted loss per share - US Cents

4

 

(2.22)

 

(6.35)

(9.29)

 

 

 

Consolidated Statement of comprehensive income

 

 

 

6 months

ended

30 September

2023

Unaudited

 

6 months

ended

30 September

2022

Unaudited

Year

 ended

31 March

2023

Audited

 

 

 

 

 

 

 

 

US$000

 

US$000

US$000

 

 

 

 

Loss for the period

 

 

(1,598)

 

(1,349)

(2,109)

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

Foreign exchange translation differences

 

 

(705)

(490)

(161)

Other comprehensive (loss)/income for the period

 

 

(705)

(490)

(161)

/Total comprehensive (loss)/income for the period attributable to owners of the Company

 

 

(2,303)

 

(1,839)

(2,270)

Consolidated statement of financial position

 

 

 

 

30 September

2023

Unaudited

30 September

2022

Unaudited

31 March

2023

Audited

 

 

 

 

 

Note

 

US$000

US$000

US$000

Non-current assets

 

 

 

 

Property, plant and equipment

 

 

23,973

24,682

24,267

Intangible assets

 

 

1

10

3

Equity-accounted investees

 

 

108

91

93

 

 

24,082

24,783

24,363

Current assets

 

 

 

Biological assets

 

 

292

421

496

Inventories

 

 

2,472

2,125

550

Trade and other receivables

 

 

1,628

1,190

1,055

Cash and cash equivalents

 

 

307

350

174

 

 

4,699

4,086

2,275

Total assets

 

 

28,781

28,869

26,638

Current liabilities

 

 

 

Borrowings

5

 

1,179

4,287

2,666

Trade and other payables

 

 

1,963

1,530

658

 

 

3,142

5,817

3,324

Net current assets

 

 

1,557

(1,731)

(1,049)

 

 

 

 

Non-current liabilities

 

 

 

Borrowings

5

 

11,820

6,968

7,196

Deferred tax liability

 

 

6,115

6,243

6,111

 

 

 

17,935

13,211

13,307

Total liabilities

 

 

21,077

19,028

16,631

 

 

 

 

Net assets

 

 

7,704

9,841

10,007

 

 

 

Share capital

6

 

63,343

3,373

3,993

Share premium

6

 

-

151,442

151,419

Share based payments reserve

 

 

67

67

67

Revaluation reserve

 

 

11,935

12,186

12,061

Translation reserve

 

 

(16,874)

(16,498)

(16,169)

Accumulated losses

 

 

(50,767)

(140,729)

(141,364)

Equity attributable to equity holders of the parent

 

 

7,704

9,841

10,007

 

 

 

 

 

The unaudited condensed consolidated financial statements of Agriterra Limited for the six months ended 30 September 2023 were approved by the Board of Directors and authorised for issue on 29 December 2023.

 

Signed on behalf of the Board of Directors:

 

 

 

 

 

CSO Havers

 

Chair

 

Consolidated statement of changes in equity

 

 

 

 

 

Share

capital

Share premium

Share based payment reserve

Translation reserve

Revaluation reserve

Accumulatedlosses

Total

Equity

Note

US$000

US$000

US$000

US$000

US$000

US$000

US$000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 April 2022

3,373

151,442

67

(16,008)

12,312

(139,506)

11,680

Loss for the period

-

-

-

-

-

(1,349)

(1,349)

Other comprehensive income:

Exchange translation gain on foreign operations restated

-

-

-

(490)

-

-

(490)

Total comprehensive loss for the period

-

-

-

(490)

-

(1,349)

(1,839)

Transactions with owners

Revaluation surplus realised

-

-

-

-

(126)

126

-

Total transactions with owners for the period

-

-

-

-

(126)

126

-

Balance at 30 September 2022

 

 

3,373

 

151,442

 

67

 

(16,498)

 

12,186

 

(140,729)

 

9,841

Loss for the period

 

 

-

-

-

-

-

(760)

(760)

Other comprehensive income:

Exchange translation gain on foreign operations

 

-

-

-

329

-

-

329

Total comprehensive income for the period

 

-

-

-

329

-

(760)

(431)

Transactions with owners

 

 

Issue of shares

 

 

620

(23)

-

-

-

-

597

Revaluation surplus realised

 

 

-

-

-

-

(125)

125

-

Total transactions with owners for the period

620

(23)

-

-

(125)

125

597

Balance at 31 March 2023

3,993

 

151,419

 

67

 

(16,169)

 

12,061

 

(141,364)

 

10,007

Loss for the period

-

-

-

-

-

(1,598)

(1,598)

Other comprehensive income:

Exchange translation (loss) on foreign operations

-

-

-

(705)

-

-

(705)

Total comprehensive loss for the period

-

-

-

(705)

-

(1,598)

(2,303)

Transactions with owners

Reclassification

59,350

(151,419)

-

-

-

92,069

-

Revaluation surplus realised

-

-

-

-

(126)

126

-

Total transactions with owners for the period

59,350

(151,419)

-

-

(126)

92,195

-

Balance at 30 September 2023

63,343

 

-

 

67

 

(16,874)

 

11,935

 

(50,767)

 

7,704

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated cash flow statement

 

 

Note

 

6 months ended

30 September

2023

Unaudited

6 months ended

30 September

2022

Unaudited

Year

 ended

31 March

2023

Audited

 

 

 

 

 

 

 

US$000

US$000

US$000

 

 

 

 

Loss before tax for the period

 

 

(1,598)

(1,349)

(2,236)

Adjustments for:

 

 

 

Amortisation and depreciation

2

 

396

435

870

Foreign exchange (gain)/loss

 

 

(315)

(493)

(151)

Decrease / (increase) in value of biological assets

 

 

-

-

288

Share of profit in associate

 

 

(15)

(35)

(37)

Net Finance costs

 

 

550

918

1,462

Operating cash flows before movements in working capital

 

 

(982)

(524)

196

Net decrease / (increase) in biological assets

 

 

204

42

(321)

(Increase) / decrease in inventories

 

 

(1,922)

51

1,626

(Increase) / decrease in trade and other receivables

 

 

(573)

(366)

52

Increase / (decrease) in trade and other payables

 

 

924

570

(302)

Net Cash used in operating activities

 

 

(2,352)

(227)

1,251

 

 

 

Cash flows from investing activities

 

 

 

Acquisition of property, plant and equipment

 

 

(102)

(58)

(90)

Net cash used in investing activities

 

 

(102)

(58)

(90)

 

 

 

Cash flow from financing activities

 

 

 

Finance costs

3

 

(167)

(918)

(1,014)

Net (repayment) / drawdown of overdrafts

5

 

-

(6,255)

(6,254)

Net (repayment) / drawdown of loans and finance leases

5

 

(146)

7,701

(1,726)

Net drawdown of shareholder loans

 

 

2,900

-

7,900

 

 

 

Net cash generated from/(used in) financing activities

 

 

2,587

528

 (1,094)

 

 

 

 

 

Net increase in cash and cash equivalents

 

 

133

243

67

Effect of exchange rates on cash and cash equivalents

 

 

-

-

-

Cash and cash equivalents at beginning of period

 

 

174

107

107

Cash and cash equivalents at end of period

 

 

307

350

174

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General information

 

Agriterra Limited ('Agriterra' or the 'Company') and its subsidiaries (together the 'Group') is focussed on the agricultural sector in Africa. Agriterra is a non-cellular company limited by shares incorporated and domiciled in Guernsey, Channel Islands. The address of its registered office is Connaught House, St Julian's Avenue, St Peter Port, Guernsey GY1 1GZ.

 

The Company's Ordinary Shares are quoted on the AIM Market of the London Stock Exchange ('AIM').

 

The unaudited condensed consolidated financial statements have been prepared in US Dollars ('US$') as this is the currency of the primary economic environment in which the Group operates.

 

1. Basis of preparation

 

The condensed consolidated financial statements of the Group for the 6 months ended 30 September 2023 (the 'H1-2024 financial statements'), which are unaudited and have not been reviewed by the Company's Auditor, have been prepared in accordance with the International Financial Reporting Standards ('IFRS'). The accounting policies adopted by the Group are set out in the annual report for the year ended 31 March 2023 (available at www.agriterra-ltd.com). The Group does not anticipate any significant change in these accounting policies for the year ended 31 March 2024.

 

This interim report has been prepared to comply with the requirements of the AIM Rules of the London Stock Exchange (the 'AIM Rules'). In preparing this report, the Group has adopted the guidance in the AIM Rules for interim accounts which do not require that the interim condensed consolidated financial statements are prepared in accordance with IAS 34, 'Interim financial reporting'. Whilst the financial figures included in this report have been computed in accordance with IFRSs applicable to interim periods, this report does not contain sufficient information to constitute an interim financial report as that term is defined in IFRSs.

 

The financial information contained in this report also does not constitute statutory accounts under the Companies (Guernsey) Law 2008, as amended. The financial information for the year ended 31 March 2023 is based on the statutory accounts for the year then ended. The Auditors reported on those accounts. Their report was unqualified and referred to going concern as a key audit matter. The Auditors drew attention to note 3 to the financial statements concerning the Group's ability to continue as a going concern which shows that the Group will need to renew its overdraft facilities, maintain its current borrowings and raise further finance in order to continue as a going concern.

 

The H1-2024 financial statements have been prepared in accordance with the IFRS principles applicable to a going concern, which contemplate the realisation of assets and liquidation of liabilities during the normal course of operations. Having carried out a going concern review in preparing the H1-2024 financial statements, the Directors have concluded that there is a reasonable basis to adopt the going concern principle.

 

 

2. Segment information

 

The Board considers that the Group's operating activities during the period comprised the segments of Grain, Beef and Snax, undertaken in Mozambique. In addition, the Group has certain other unallocated expenditure, assets and liabilities.

The following is an analysis of the Group's revenue and results by operating segment:

 

6 months ended 30 September 2023 - Unaudited

 

Grain

 

Beef

 

Snax

 

Unallo-cated

 

Elimina-tions

 

Total

US$000

 

US$000

 

US$000

 

US$000

 

US$000

 

US$000

Revenue

 

 

 

 

 

 

 

 

 

 

 

External sales(2)

2,066

 

1,509

 

-

 

-

 

-

 

3,575

Inter-segment sales(1)

117

 

-

 

-

 

-

 

(117)

 

-

2,183

 

1,509

 

-

 

-

 

(117)

 

3,575

 

 

 

 

 

 

 

 

 

 

 

Segment results

 

 

 

 

 

 

 

 

 

 

 

- Operating loss

(620)

 

(316)

 

-

 

(256)

 

-

 

(1,192)

- Interest expense

(184)

 

(70)

 

-

 

(296)

 

-

 

(550)

- Share of profit in equity accounted investees

-

 

-

 

15

 

-

 

-

 

15

- Other gains and losses

128

 

1

 

-

 

-

 

-

 

129

(Loss)/Profit before tax

(676)

 

(385)

 

15

 

(552)

 

-

 

(1,598)

 

 

 

 

 

 

 

 

 

 

 

Income tax

-

 

-

 

-

 

-

 

-

 

-

(Loss)/Profit for the period

(676)

 

(385)

 

15

 

(552)

 

-

 

(1,598)

 

 

 

 

6 months ended 30 September 2022 - Unaudited

 

Grain

Beef

Snax

Unallo-cated

Elimina-tions

Total

US$000

US$000

US$000

US$000

US$000

US$000

Revenue

External sales(2)

3,309

1,655

-

-

-

4,964

Inter-segment sales(1)

245

-

-

-

(245)

-

3,554

1,655

-

-

(245)

4,964

Segment results

- Operating loss

(141)

(264)

-

(127)

-

(532)

- Interest expense

(776)

(27)

-

(115)

-

(918)

- Share of profit in equity accounted investees

-

-

35

-

-

35

- Other gains and losses

47

19

-

-

-

66

(Loss)/Profit before tax

(870)

(272)

35

(242)

-

(1,349)

Income tax

-

-

-

-

-

-

(Loss)/Profit for the period

(870)

(272)

35

(242)

-

(1,349)

 

 

 

 

Year ended 31 March 2023 - Audited

 

Grain

Beef

Snax1

Unallo-cated

Elimina-tions

Total

US$000

US$000

US$000

US$000

US$000

US$000

Revenue

 

 

 

 

 

 

 

 

 

 

 

External sales(2)

8,365

 

3,129

 

-

 

-

 

-

 

11,494

Inter-segment sales(1)

225

 

-

 

-

 

-

 

(225)

 

-

8,590

 

3,129

 

-

 

-

 

(225)

 

11,494

Segment results

 

 

 

 

 

 

 

 

 

 

 

- Operating loss

2

 

(659)

 

-

 

(308)

 

-

 

(965)

- Interest expense

(958)

 

(63)

 

-

 

(441)

 

-

 

(1,462)

- Other gains and losses

95

 

59

 

-

 

-

 

-

 

154

-Share of profit in equity-accounted investees

-

 

-

 

37

 

-

 

-

 

37

(Loss)/Profit before tax

(861)

 

(663)

 

37

 

(749)

 

-

 

(2,236)

Income tax

115

12

-

-

 

-

 

127

(Loss)/Profit after tax

(746)

(651)

37

(749)

-

(2,109)

 

 

(1) Inter-segment sales are charged at prevailing market prices

(2) Revenue represents sales to external customer and is recorded in the country of domicile of the Company making the sales. Sales from the Grain and the Beef divisions are principally for supply to the Mozambique market.

 

The segment items included within continuing operations in the consolidated income statement for the periods are as follows:

 

 

Grain

 

Beef

 

Unallo-cated

 

Elimina-tions

 

Total

US$000

 

US$000

 

US$000

 

US$000

 

US$000

6 months ended 30 September 2023 - Unaudited

 

 

 

 

 

 

 

 

 

Depreciation and amortisation

236

 

160

 

-

 

-

 

396

6 months ended 30 September 2022 - Unaudited

Depreciation and amortisation

257

178

-

-

435

 

Year ended 31 March 2023 - Audited

Depreciation and amortisation

514

356

-

-

870

 

3. NET FINANCE COSTS

 

6 months ended

30 September

2023

Unaudited

6 months ended

30 September

2022

Unaudited

Year

 ended

31 March

2023

Audited

US$000

US$000

US$000

Interest expense:

 

 

Bank loans, overdrafts and finance leases

550

918

1,462

Interest income:

 

 

Bank deposits

-

-

-

550

918

1,462

 

 

 

4. LOSS per share

 

The calculation of the basic and diluted loss per share is based on the following data:

 

 

6 months

 ended

 

6 months

 ended

Year

 ended

 

30 September

 

30 September

31 March

 

2023

 

2022

2023

 

Unaudited

 

Unaudited

Audited

 

US$000

 

US$000

US$000

 

 

 

Loss for the period/year for the purposes of basic and diluted earnings per share attributable to equity holders of the Company

 

(1,598)

 

(1,349)

(2,109)

 

 

 

Weighted average number of Ordinary Shares for the purposes of basic and diluted loss per share

 

 

71,829,007

 

21,240,618

22,240,618

 

 

 

Basic and diluted loss per share - US cents

 

(2.22)

 

(6.35)

(9.29)

 

The Company has issued options over ordinary shares which could potentially dilute basic loss per share in the future. There is no difference between basic loss per share and diluted loss per share as the potential ordinary shares are anti-dilutive.

 

 

5. Borrowings

30 September 2023

 

30 September 2022

31 March

2023

Unaudited

 

Unaudited

Audited

US$000

 

US$000

US$000

 

 

 

Non-current

 

 

Shareholder loan

11,317

6,215

6,534

Bank loans

503

595

574

Leases

-

158

88

 

11,820

6,968

7,196

Current

 

Shareholder loan

-

1,800

1,500

Bank loans

1,058

2,377

1,056

Leases

121

110

110

1,179

4,287

2,666

 

12,999

11,255

9,862

 

 

Group

 

During the period, Agriterra Limited secured shareholder loans amounting to US$ 2.9 million from Magister Investments Limited at an interest rate of SOFR+6% to reduce the finance grain working capital as well acquisition of the biscuit plant. The new shareholder loans were issued during the period to add to the following existing shareholder loan;

 

· US$ 6.1 million convertible loan facility with a 3 year tenure maturing August 2024.

· US$ 1.8 million convertible loan facility with a 12 month tenure maturing in August 2023, loan has been rolled over with an option to automatically rollover for more periods.

 

Grain division

 

Grain division has two outstanding commercial bank loans amounting to US$ 1.6 million. Bank loan with an outstanding balance of US$ 0.9 million was issued in May 2019. The loan facility which was originally issued as an overdraft facility has been restructured several times and now is a term loan incurring an interest rate of Bank's prime lending rate less 1.75% and matures in July 2023. The group subsequently repaid the outstanding loan in October 2023 using a shareholder loan. The second debt facility with an outstanding balance of US$ 0.7 million is a 5 year term loan maturing on 31 December 2025. The facility was restructured into a term loan on 1 December 2021 with an interest of prime lending rate plus 1.5%. These facilities are secured by land and buildings.

 

In addition, Grain division has a finance lease for 6 vehicles maturing on 05 December 2023 with an outstanding balance amounting to MZN 1.6 million (approximately US$ 25,000). Grain division incurs interest of 18.6% on this facility. During the period MZN 1.6 million (approximately US$ 25,000) of the outstanding balance was repaid.

 

 

Beef division

 

The outstanding balance on agricultural equipment finance lease is MZN 6.1 million (approximately US$ 0.1 million). During the period, MZN 3.3 million (approximately US$ 51,000) of the principal balance was repaid. The finance lease is repayable over 5 years maturing in July 2024 and is secured against certain agricultural equipment.

 

 

Reconciliation to cash flow statement

 

 

At 31

 March

2023

 

Cash flow

 

Interest accrued

 

Foreign Exchange

 

At 30 September 2023

 

US$000

US$000

US$000

 

US$000

US$000

Non-current shareholder loan

8,034

2,900

384

(1)

11,317

Non-current bank loans

574

(71)

-

-

503

Non-current finance leases

88

(88)

-

-

-

Current bank loans

1,056

2

-

-

1,058

Current finance leases

110

11

-

-

121

 

 

 

9,862

2,754

384

(1)

12,999

 

 

6. Share capital

Authorised

 

Allotted and fully paid

 

 

 

Number

 

Number

 

US$000

Ordinary Shares

 

 

 

 

 

 

At 30 September 2022

23,450,000

 

21,240,618

 

3,135

Issued during the period

50,588,389

 

50,588,389

 

620

At 31 March 2023

74,038,389

 

71,829,007

 

3,755

Reclassification

-

 

-

 

59,350

At 30 September 2023

74,038,389

 

71,829,007

 

63,105

At 31 March 2023 and September 2023

-

 

-

 

-

Deferred shares of 0.1p each

155,000,000

 

155,000,000

 

238

 

 

 

 

 

Total share capital

229,038,389

 

226,829,007

 

63,343

 

 

The Company has one class of ordinary share which carries no right to fixed income.

 

The deferred shares carry no right to any dividend; no right to receive notice, attend, speak or vote at any general meeting of the Company; and on a return of capital on liquidation or otherwise, the holders of the deferred shares are entitled to receive the nominal amount paid up after the repayment of £1,000,000 per ordinary share. The deferred shares may be converted into ordinary shares by resolution of the Board.

 

At 30 September 2023, the Company offset accumulated losses of US$ 92,069,000 against the share premium account and the balance of US$ 59,350,000 remaining on the share premium account has been combined with the share capital account to comply with Guernsey company law.

 

7. Post balance sheet events

 

On 15 November 2023, Magister Investments Limited advanced a further $1.7 million to enable the Group to repay its remaining Metical denominated bank borrowings. The loan has a coupon of SOFR+6% and a term of 1 year, renewable at the lender's option

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EAEANAAFDFFA
Date   Source Headline
9th Jan 20243:00 pmRNSResult of AGM
29th Dec 202310:30 amRNSHalf-year Report
12th Dec 202311:00 amRNSNotice of Annual General Meeting
1st Dec 20233:37 pmRNS2023 Annual Results and Trading Restoration
1st Dec 20233:30 pmRNSRestoration - Agriterra Limted
15th Nov 20237:00 amRNSNew Term Loan and Related Party Transaction
26th Oct 20232:30 pmRNS2023 Annual Accounts Timetable Update
2nd Oct 20237:30 amRNSSuspension - Agriterra Limited
11th Sep 20233:30 pmRNS2023 Annual Accounts Timetable
18th Aug 20237:00 amRNSNew Trade Finance Package and RPT
14th Jun 202311:30 amRNSDebt facility and Related Party Transaction
30th Mar 202311:30 amRNSHolding(s) in Company
30th Mar 202311:30 amRNSHolding(s) in Company
30th Mar 202310:32 amRNSHolding(s) in Company
28th Mar 20238:00 amRNSHolding(s) in Company
23rd Mar 202310:40 amRNSFurther Debt Conversion and TVR
23rd Mar 20238:00 amRNSHolding(s) in Company
22nd Mar 202311:40 amRNSResult of Broker Option and TVR
20th Mar 20234:40 pmRNSSecond Price Monitoring Extn
20th Mar 20234:35 pmRNSPrice Monitoring Extension
20th Mar 20237:45 amRNSPlacing, Broker Option and PILOW Instrument
23rd Feb 20233:00 pmRNSHolding(s) in Company
9th Jan 20237:00 amRNSChange of Registered Office
21st Dec 20224:40 pmRNSSecond Price Monitoring Extn
21st Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 202210:00 amRNSInterim Results
7th Dec 20224:17 pmRNSResult of AGM
10th Nov 20229:30 amRNSNotice of Annual General Meeting
30th Sep 20229:00 amRNSPosting of 2022 Annual Accounts
30th Sep 20227:00 amRNSAnnual Financial Report
29th Jul 20223:00 pmRNSDebt Refinancing and Working Capital Loan
20th Jul 202211:16 amRNSAppointment of Broker
20th Jun 20221:15 pmRNSBoard Changes
31st Mar 20227:00 amRNSTrading Update
15th Dec 20212:30 pmRNSHY-2022 Interim Results
12th Nov 20212:00 pmRNSChair of Agriterra recognised in Chairperson Award
1st Nov 20214:35 pmRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSFinal Results
30th Sep 20214:41 pmRNSSecond Price Monitoring Extn
30th Sep 20214:36 pmRNSPrice Monitoring Extension
29th Sep 202110:30 amRNSTrading Update and 2021 Annual Accounts Timetable
15th Jul 20211:45 pmRNSUS$6.1m refinancing and Related Party Transaction
21st May 202112:00 pmRNSTrading Update
21st Apr 202110:45 amRNSAppointment of CEO and Board Changes
29th Jan 20212:30 pmRNSResult of AGM
29th Jan 20217:00 amRNSInterim Results
31st Dec 202011:00 amRNS2020 Annual Report Posting & Notice of AGM
24th Dec 20201:15 pmRNSAnnual Results for Year Ended 31 March 2020
27th Nov 202012:10 pmRNS2020 Annual Accounts Timetable Update
19th Oct 20202:15 pmRNS2020 Annual Accounts Timetable Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.